XOMA: XOMA Royalty Corporation Stock

by  •  • Comments Off on XOMA: XOMA Royalty Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 241.55
Enterprise Value ($M) 217.46
Book Value ($M) 84.81
Book Value / Share 7.20
Price / Book 2.85
NCAV ($M) 20.49
NCAV / Share 1.74
Price / NCAV 11.79

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.13
Return on Equity (ROE) -0.34

Liquidity (mrq)
Quick Ratio 7.52
Current Ratio 7.52

Balance Sheet (mrq) ($M)
Current Assets 159.02
Assets 223.34
Liabilities 138.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-28 13D/A Biotechnology Value Fund L P 25.30 -17.91

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-12 5,156 13,800 37.36
2025-03-11 3,959 21,765 18.19
2025-03-10 4,262 34,739 12.27
2025-03-07 8,991 69,951 12.85

(click for more detail)

Similar Companies
WVE – Wave Life Sciences Ltd. XENE – Xenon Pharmaceuticals Inc.
XNCR – Xencor, Inc.


Financial data and stock pages provided by
Fintel.io